---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-028921"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2025-12-23T23:59:59+00:00"
generated_at: "2026-05-16T12:22:39.784312+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Oncotelic launches PDAOAI platform and opens TGF-β corpus access

## Summary
- Launched PDAOAI, an evidence-interrogation platform for extracting biological signals from large datasets without training custom LLMs.
- Providing open access to a TGF-β literature corpus of over 125,000 PubMed abstracts via a dedicated Discord research channel.
- Platform aims to enable researchers to analyze complex biomedical data without proprietary data training.

## SEC filing metadata
- accession: 0001493152-25-028921
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2025-12-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315225028921/0001493152-25-028921-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315225028921/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-028921
- JSON: https://secwatch.observer/filing/0001493152-25-028921.json
- Plain text: https://secwatch.observer/filing/0001493152-25-028921.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.